VAM
TECH icon

Visium Asset Management’s Bio-Techne TECH Stock Holding History

Visium Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-120,000
Closed -$2.07M – 863
2013
Q2 		$2.07M Buy
+120,000
New +$1.99M 0.05% 230

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Visium Asset Management's TECH Position: Q3 2013 in Review

Visium Asset Management sold out of Bio-Techne (TECH) in Q3 2013, closing a stake of 120,000 shares — an estimated $2.07M sold.

Visium Asset Management first reported a position in TECH in Q2 2013 and held it in 1 quarter. The position peaked at $2.07M in Q2 2013. 248 funds tracked by Wall St. Rank hold TECH as of Q3 2013.

  • Visium Asset Management reported no remaining Bio-Techne position as of Q3 2013 after selling out during the quarter.
  • Visium Asset Management sold 120,000 Bio-Techne shares in Q3 2013, an estimated $2.07M.
  • Visium Asset Management first reported a position in Bio-Techne in Q2 2013 and held it in 1 quarter.
  • Visium Asset Management's Bio-Techne position peaked at $2.07M in Q2 2013.
  • 248 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2013.

Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.